Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.
C
C

Celanese

Balita

Reuters - 1 linggo ang nakaraan

RBC Capital Markets sees dour Q3 for chemical commodity companies

BUZZ-RBC Capital Markets sees dour Q3 for chemical commodity companies ** RBC Capital Market's earnings expectations for commodity chemical companies in second half of 2024 have come down further due to ongoing Europe weakness and unplanned outages through Q3 ** While businesses and consumer demand could improve on interest rate cuts, benefits not
D
C
E
Reuters - 1 linggo ang nakaraan

U.S. ANI Pharmaceuticals, Deere & Co, Zoetis

U.S. RESEARCH ROUNDUP-ANI Pharmaceuticals, Deere & Co, Zoetis Oct 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including ANI Pharmaceuticals, Deere & Co and Zoetis, on Friday. HIGHLIGHTS * ANI Pharmaceuticals Inc ANIP.O : Piper Sandler initiates coverage with overweight rating * Deere & Co DE.N : JP Morgan raises target price to $420 from $360 * Northrop Grumman NOC.N : Citigroup raises target price to $587 from $521 * S
A
C
G
H
I
A
C
F
A
C
A
A
C
C
C
E
Reuters - 1 buwan ang nakaraan

U.S. Avalonbay Communities, Elf Beauty, Evercore

U.S. RESEARCH ROUNDUP-Avalonbay Communities, Elf Beauty, Evercore Sept 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Avalonbay Communities, Elf Beauty and Evercore on Monday. HIGHLIGHTS * Avalonbay Communities Inc AVB.N : JP Morgan raises target price to $247 from $212 * Colgate-Palmolive Co CL.N : Wells Fargo cuts to underweight from equal-weight * Elf Beauty Inc ELF.N : Piper Sandler cuts target price to $162
C
G
G
I
C
E
E
C
Reuters - 1 buwan ang nakaraan

U.S. Coca-Cola, KB Home, Newmark Group

U.S. RESEARCH ROUNDUP-Coca-Cola, KB Home, Newmark Group Sept 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Coca-Cola, KB Home and Newmark Group on Thursday. HIGHLIGHTS * Capital Clean Energy Carriers CCEC.O : Evercore ISI initiates coverage with outperform rating * Coca-Cola Co KO.N : CFRA cuts to hold from buy * KB Home KBH.N : RBC cuts to underperform from sector perform * Newmark Group Inc NMRK.O : KBW raises
B
U
C
D
C
C
L
Reuters - 2 buwan ang nakaraan

U.S. Airbnb, Dollar General, Walmart

U.S. RESEARCH ROUNDUP-Airbnb, Dollar General, Walmart Aug 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Airbnb, Dollar General and Walmart, on Monday. HIGHLIGHTS * Airbnb Inc ABNB.O : Jefferies cuts target price to $125 from $150 * Dollar General Corp DG.N : Jefferies cuts target price to $145 from $160 * Hilton Grand Vacations Inc HGV.N : JP Morgan cuts to neutral from overweight * Pacira Biosciences Inc PCRX.O
A
E
T
A
D
D
C
F
Reuters - 2 buwan ang nakaraan

Celanese Underlying Supply Chain Conditions Behind Declaration Have Stabilized

BRIEF-Celanese Underlying Supply Chain Conditions Behind Declaration Have Stabilized Aug 8 (Reuters) - Celanese Corp CE.N : CELANESE CORPORATION LIFTS FORCE MAJEURE ON WESTERN HEMISPHERE ACETIC ACID AND VAM CELANESE CORP: UNDERLYING SUPPLY CHAIN CONDITIONS BEHIND DECLARATION HAVE STABILIZED Source text for Eikon: ID:nBw5Tt5YRa Further company cover
C
Reuters - 2 buwan ang nakaraan

Celanese lifts force majeure condition for some products sold in western hemisphere

Celanese lifts force majeure condition for some products sold in western hemisphere Aug 8 (Reuters) - Specialty chemicals maker Celanese CE.N said on Thursday it had lifted the force majeure condition it invoked in the second quarter for its acetic acid and vinyl acetate monomer products sold in the western hemisphere after supply conditions improved.
C
Reuters - 2 buwan ang nakaraan

U.S. Amphastar Pharmaceuticals, G1 Therapeutics, Upwork

U.S. RESEARCH ROUNDUP-Amphastar Pharmaceuticals, G1 Therapeutics, Upwork Aug 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amphastar Pharmaceuticals, G1 Therapeutics and Upwork on Thursday. HIGHLIGHTS * Amphastar Pharmaceuticals Inc AMPH.O : Piper Sandler cuts target price to $66 from $71 * Charles River Laboratories International Inc CRL.N : Baird cuts to neutral * G1 Therapeutics Inc GTHX.O : H.C.
A
A
C
G
A
C
I
Reuters - 2 buwan ang nakaraan

U.S. Booking Holdings, Doordash, Vertex Pharmaceuticals

U.S. RESEARCH ROUNDUP- Booking Holdings, Doordash, Vertex Pharmaceuticals Aug 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Booking Holdings, Doordash and Vertex Pharmaceuticals, on Monday. HIGHLIGHTS * Academy Sports and Outdoors Inc ASO.O : JP Morgan cuts to neutral from overweight * Booking Holdings Inc BKNG.O : Jefferies cuts target price to $4350 from $4650 * Doordash DASH.O : D.A.
A
B
C
C
C
C
E
V
E
A
B
C
C
C
C
Reuters - 3 buwan ang nakaraan

Celanese cuts 2024 profit forecast on sluggish demand, production snags

Celanese cuts 2024 profit forecast on sluggish demand, production snags Aug 1 (Reuters) - Specialty chemicals company Celanese CE.N lowered its 2024 earnings forecast on Thursday, hurt by weak demand in several key sectors and production obstacles, sending its shares down 5.4% after the bell. China's manufacturing activity contracted in May and June , with economic data in the last month of the quarter showing indexes of raw material stocks in contractionary territory.
C
Reuters - 3 buwan ang nakaraan

Celanese Corp <CE.N> expected to post earnings of $2.71 a share - Earnings Preview

Celanese Corp expected to post earnings of $2.71 a share - Earnings Preview Celanese Corp CE.N , CE is expected to show a fall in quarterly revenue when it reports results on August 1 for the period ending June 30 2024 The Irving Texas-based company is expected to report a 1.5% decrease in revenue to $2.754 billion from $2.8 billion a year ago, according to the mean estimate from 14 analysts, based on LSEG data.
C

Kundisyon

Mga Patok na Assets

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.